DE69106237D1 - Antimigräne Alkoxypyrimidinderivate. - Google Patents

Antimigräne Alkoxypyrimidinderivate.

Info

Publication number
DE69106237D1
DE69106237D1 DE69106237T DE69106237T DE69106237D1 DE 69106237 D1 DE69106237 D1 DE 69106237D1 DE 69106237 T DE69106237 T DE 69106237T DE 69106237 T DE69106237 T DE 69106237T DE 69106237 D1 DE69106237 D1 DE 69106237D1
Authority
DE
Germany
Prior art keywords
migraine
alkoxypyrimidine
derivatives
alkoxypyrimidine derivatives
indolylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106237T
Other languages
English (en)
Other versions
DE69106237T2 (de
Inventor
David W Smith
Frank D Yocca
Joseph P Yevich
Ronald J Mattson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE69106237D1 publication Critical patent/DE69106237D1/de
Application granted granted Critical
Publication of DE69106237T2 publication Critical patent/DE69106237T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
DE69106237T 1990-06-29 1991-06-24 Antimigräne Alkoxypyrimidinderivate. Expired - Fee Related DE69106237T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54612290A 1990-06-29 1990-06-29
US68020891A 1991-04-04 1991-04-04
SG15595A SG15595G (en) 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives

Publications (2)

Publication Number Publication Date
DE69106237D1 true DE69106237D1 (de) 1995-02-09
DE69106237T2 DE69106237T2 (de) 1995-05-11

Family

ID=27356028

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106237T Expired - Fee Related DE69106237T2 (de) 1990-06-29 1991-06-24 Antimigräne Alkoxypyrimidinderivate.

Country Status (15)

Country Link
US (1) US5300506A (de)
EP (1) EP0464558B1 (de)
JP (1) JPH04230378A (de)
AT (1) ATE116312T1 (de)
AU (1) AU643038B2 (de)
CA (1) CA2043709C (de)
CY (1) CY1831A (de)
DE (1) DE69106237T2 (de)
DK (1) DK0464558T3 (de)
ES (1) ES2066278T3 (de)
FI (1) FI101224B (de)
HK (1) HK51995A (de)
IE (1) IE66687B1 (de)
PT (1) PT98115B (de)
SG (1) SG15595G (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226610D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
US5550239A (en) * 1994-11-08 1996-08-27 Bristol-Myers Squibb Company Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
WO1997000244A1 (en) * 1995-06-19 1997-01-03 Eli Lilly And Company Process for parallel synthesis of a non-peptide library
US5889008A (en) * 1995-08-07 1999-03-30 Merck Sharp & Dohme, Ltd. Substituted 1-indolylpropyl-4-phenethylpiperazadine derivatives
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
US6800637B2 (en) 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
EP1632491A1 (de) * 2004-08-30 2006-03-08 Laboratorios Del Dr. Esteve, S.A. Substituierte indol-verbindungen und deren verwendung als modulatoren des 5-ht6 rezeptors
EP1931648A2 (de) * 2006-08-29 2008-06-18 Teva Pharmaceutical Industries Ltd. Verfahren zur synthese von 5-phenyl-1-trityl-1h-tetrazol
EP2036888A1 (de) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Naphthyl-substituierte Sulfonamide
AU2009225025A1 (en) * 2008-03-14 2009-09-17 Merck Patent Gmbh Azaindole compounds for treatment of central nervous system disorders
US20090281114A1 (en) * 2008-05-08 2009-11-12 Fabre-Kramer Pharmaceuticals, Inc. Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
EP3027607B1 (de) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituierte heteroarylverbindungen und verfahren zur verwendung davon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (de) * 1959-09-25 1900-01-01
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
BE763838A (fr) * 1970-03-06 1971-08-02 Sumitomo Chemical Co Nouveau procede de preparation de derives de piperazinobutyrophenone
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines

Also Published As

Publication number Publication date
HK51995A (en) 1995-04-13
FI913142A0 (fi) 1991-06-27
CA2043709C (en) 2002-01-22
ES2066278T3 (es) 1995-03-01
CY1831A (en) 1995-12-01
JPH04230378A (ja) 1992-08-19
ATE116312T1 (de) 1995-01-15
DK0464558T3 (da) 1995-03-13
PT98115B (pt) 1998-12-31
EP0464558A1 (de) 1992-01-08
IE912280A1 (en) 1992-01-01
FI101224B1 (fi) 1998-05-15
FI913142A (fi) 1991-12-30
CA2043709A1 (en) 1991-12-30
PT98115A (pt) 1992-03-31
FI101224B (fi) 1998-05-15
US5300506A (en) 1994-04-05
IE66687B1 (en) 1996-01-24
EP0464558B1 (de) 1994-12-28
AU643038B2 (en) 1993-11-04
AU7941691A (en) 1992-01-02
SG15595G (en) 1995-06-16
DE69106237T2 (de) 1995-05-11

Similar Documents

Publication Publication Date Title
DE69106237D1 (de) Antimigräne Alkoxypyrimidinderivate.
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
KR900009625A (ko) 피리미딘류 및 그의 약리학적으로 허용되는 염류 및 그 용도
DK0396083T3 (da) Heterocykliske N-oxidderivater af substituerede benzo(5,6)-cycloheptapyridiner, præparater og anvendelsesfremgangsmåder
PT100300B (pt) Derivados de aminas heterociclicas-ciclicas, nomeadamente derivados de benzisoxazole-piperidina
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
FI911980A0 (fi) N-(3-fluor-2-fosfonylmetoxipropyl) -derivat av heterocykliska purin- och pyrimidinbaser, deras framstaellning och anvaendning.
ITRM920688A0 (it) Apparecchio per l'analisi topografica di superfici anatomiche, in particolare della cornea
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
DE59107445D1 (de) Kombination von Arbeitsgerät und höhenverstellbare Versorgungseinheit
NO903640L (no) Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner.
DK0492841T3 (da) Anti-herpes-castanosperminestere
HK1005016A1 (en) Use of buspirone in sleep apneas
DE3777665D1 (de) Heptanoyl-glu-asp-ala-amino-saeure-immunstimulanten.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
DK422688D0 (da) Substituerede pyridylethanolaminer og fysiologisk acceptable salte og n-oxider deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
ITMI911483A1 (it) Procedimento e macchina per la lavorazione del binario
FI945035A (fi) Pintasterilisointi laserkäsittelyn avulla

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee